Fernanda Cerqueira

Senior Associate Director The Michael J. Fox Foundation for Parkinson's Research

Seminars

Tuesday 3rd February 2026
Restoring Endo-Lysosomal Function: Translational Biomarkers to Accelerate Parkinson’s Therapeutics
3:30 pm
  • Discovering metabolomic and lipidomic signatures of endolysosomal dysfunction in PD patients and healthy controls to define disease-relevant biomarker baselines
  • Validating pharmacodynamic biomarkers via small molecule target manipulation in cell and patient-derived samples to track treatment effects early in the pipeline
  • Accelerating drug discovery by using these biomarkers to derisk candidate selection, inform dose selection, and shorten time to clinical proof-of-concept in Parkinson’s
Thursday 5th February 2026
Panel Discussion: Patient Perspectives in Neurodegeneration: Shaping the Future of Alzheimer’s & Parkinson’s Drug Development
9:00 am
  • Hear directly from individuals living with Alzheimer’s and Parkinson’s alongside leading foundations, offering a unified view of lived experience and scientific context
  • Explore real-world treatment challenges, clinical trial barriers, and the outcomes that matter most to patients across both diseases
  • Gain actionable, patient-driven insights to inform more inclusive, meaningful, and effective drug development and trial design
Fernanda Cerqueira, Senior Associate Director - Research Programs & Translational, The Michael J. Fox Foundation for Parkinson's Research - 14th Alzheimers & Parkinsons Drug Development Summit